Full-Time

Clinical Pharmacy Consultant

Updated on 8/1/2026

Deadline 9/30/26
Marsh

Marsh

10,001+ employees

Global insurance brokerage and risk advisory

Compensation Overview

$132.5k - $265k/yr

+ Performance-based incentives

Houston, TX, USA + 7 more

More locations: San Francisco, CA, USA | Los Angeles, CA, USA | Chicago, IL, USA | Phoenix, AZ, USA | Denver, CO, USA | Portland, OR, USA | Atlanta, GA, USA

Hybrid

At least three days per week in the office is required.

Category
Medical, Clinical & Veterinary (1)
Required Skills
Word/Pages/Docs
Excel/Numbers/Sheets

Get referred to Marsh

See people who can refer or advise you

Requirements
  • An active, unencumbered pharmacy license is required.
  • At least 7 years of relevant work experience in clinical pharmacy is required.
  • Ability to navigate Microsoft Office tools, including Word, Excel, PowerPoint, and Teams.
  • Clinical acumen to evaluate specialty medication regimens and make evidence-based recommendations to shape members’ care.
  • Ability to prioritize and handle multiple tasks in a demanding work environment.
  • Ability to communicate highly technical information in a non-technical fashion and produce strong business writing.
  • Ability to partner with and lead teams to produce client deliverables.
  • Ability to work independently and as part of a team.
Responsibilities
  • Act as the specialty pharmacy resource for assigned clinical teams to assist in identifying and managing potential and actual high-cost claimants.
  • Interpret pharmacy data reporting shared by benefit administrators and use it to select high-cost claimant cases for review.
  • Participate in discussions with benefit administrators’ clinical teams to identify strengths and opportunities in case management and suggest how members’ care should proceed.
  • Create clear and constructive summary reports for Mercer Health and Benefits teams, coalition partners, and clients.
  • Participate in Pharmacy Practice meetings and communicate Mercer’s perspective on effective pharmacy clinical management strategies.
  • Incorporate compliance and professional standards into work processes, including transparency, peer review, and maintenance of required licensure.
  • Monitor project success in terms of client satisfaction, scope, and timeliness of deliverables.
  • Establish effective carrier and vendor relationships to represent Mercer and serve clients.
  • Provide mentoring and coaching to team members on specialty medications and pharmacy management.
  • Assist in developing training presentations and learning collateral used to influence care outcomes, tailoring technical information to different audience levels and communication modes.
  • Support wellness consulting projects by providing pharmacy subject-matter expertise to cross-functional teams working on chronic-condition management.
  • Conduct pharmacy assessments to support Mercer’s clinical care management model across managed-care organizations.
  • Assist with other consulting projects as needed.
Desired Qualifications
  • A Pharm.D. degree from an accredited college of pharmacy.
  • Certified Specialty Pharmacy certification with the National Association of Specialty Pharmacy.
  • Experience supporting infused specialty medications.
  • Experience in managed-care settings.
  • Background in case-management review of specialty medications, including site-of-care review.
  • Experience conducting prior-authorization reviews.
  • Clinical payer or carrier experience, including demonstrated clinical leadership.

Marsh is a diversified professional services firm that helps clients manage risk, secure insurance, and design risk-transfer programs. Its core work combines risk advisory with insurance brokerage, acting as a buyer of coverage and placing policies across multiple underwriters. It includes Mercer (HR consulting), Guy Carpenter (reinsurance brokerage), and Oliver Wyman (management consulting) under a holding structure. Its goal is to lower clients' financial risk and total cost of risk by combining risk transfer with advisory and consulting services across insurance, reinsurance, HR, and business strategy.

Company Size

10,001+

Company Stage

Seed

Total Funding

$110K

Headquarters

New York City, New York

Founded

1871

Get referred to Marsh

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q1 revenue reached $7.6 billion, with 5% organic growth.
  • EMEA revenue rose 14.1%, showing international expansion traction.
  • Japan acquisition and port-blockage products deepen specialty distribution and niche pricing power.

What critics are saying

  • Guy Carpenter organic growth missed estimates, signaling reinsurance share pressure.
  • Consulting demand depends on discretionary corporate spending and can decelerate quickly.
  • Rebranding concentrates reputation risk across Marsh McLennan's entire platform.

What makes Marsh unique

  • Broker-as-buyer model creates client-first insurance placement expertise.
  • Marsh McLennan scale combines brokerage, reinsurance, consulting, and talent advisory.
  • Specialty coverage spans cyber, climate, supply-chain, and geopolitical risks.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Paid Vacation

Paid Sick Leave

Hybrid Work Options

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Professional Development Budget

Tuition Reimbursement

Mental Health Support

Paid Holidays

Company News

Smartbroker Holding AG
Jul 28th, 2025
Mitsubishi Electric to Transfer Shares of Insurance Subsidiary to Marsh Japan

28.07.2025 - Mitsubishi Electric Corporation (TOKYO: 6503) announced today that it has concluded a share transfer agreement under which it will transfer shares of its Tokyo-based subsidiary Mitsubishi Electric Insurance Service Co., Ltd. to Marsh Japan, Inc. on ...

Coverager
Aug 28th, 2024
Marsh Launches Port Blockage Insurance

Marsh <i class="fa fa-info-circle company-popover" data-content="h3Marsh/h3. div. table

Business Wire
May 16th, 2024
Marsh Mclennan Stockholders Re-Elect Board Of Directors During 2024 Meeting

NEW YORK--(BUSINESS WIRE)--Marsh McLennan (NYSE: MMC), the world’s leading professional services firm in the areas of risk, strategy, and people, today announced the results of its 2024 Annual Meeting of Stockholders. Stockholders elected the entire slate of 2024 director nominees for a one-year term expiring at next year’s annual meeting. The 11 directors are: Anthony K. Anderson, John Q. Doyle, Oscar Fanjul, H. Edward Hanway, Judith Hartmann, Deborah C

Coverager
May 9th, 2024
Marsh Introduces Micassure

Marsh <i class="fa fa-info-circle company-popover" data-content="h3Marsh/h3. div. table

Coverager
May 2nd, 2024
Marsh Launches Sentrisk

Marsh <i class="fa fa-info-circle company-popover" data-content="h3Marsh/h3. div. table